Your browser doesn't support javascript.
loading
Causes and risk factors for early death in adult patients with acute promyelocytic leukemia: a real-life experience.
Fontes, Heloísa Maria Farias; de Freitas, Júlia Peres; Oliveira, José Henrique Vanderlei; de Sousa Moraes, Édyla Almeida; Rego, Eduardo Magalhães; Melo, Raul Antônio Morais.
Affiliation
  • Fontes HMF; Universidade de Pernambuco, Faculdade de Ciências Médicas, Travessa Jackson Pollock, Recife, PE 52171-011, Brazil. Electronic address: Heloisa.farias@upe.br.
  • de Freitas JP; Universidade de Pernambuco, Faculdade de Ciências Médicas, Travessa Jackson Pollock, Recife, PE 52171-011, Brazil.
  • Oliveira JHV; Universidade de Pernambuco, Faculdade de Ciências Médicas, Travessa Jackson Pollock, Recife, PE 52171-011, Brazil.
  • de Sousa Moraes ÉA; Universidade de Pernambuco, Programa de Pós-Graduação em Biologia Celular e Molecular Aplicada, Instituto de Ciências Biológicas, Rua Arnóbio Marques, 310, Recife, PE 50100-130, Brazil; Hemope - Fundação de Hematologia e Hemoterapia de Pernambuco, Rua Joaquim Nabuco, 171, Recife, PE 52011-000, Brazi
  • Rego EM; Universidade de São Paulo, Faculdade de Medicina, Departamento de Clínica Médica, LIM-31, Hematologia e Hemoterapia, Rua Dr Eneas de Carvalho Aguiae 155, 1 andar, São Paulo, SP CEP 05403-000, Brazil.
  • Melo RAM; Universidade de Pernambuco, Faculdade de Ciências Médicas, Travessa Jackson Pollock, Recife, PE 52171-011, Brazil.
Article in En | MEDLINE | ID: mdl-38582745
ABSTRACT

INTRODUCTION:

Early Death (ED) remains challenging in newly diagnosed acute promyelocytic leukemia (APL), especially in developing countries. The clinical and laboratory profile at diagnosis were evaluated and causes and risk factors were investigated in adult APL patients.

METHOD:

A retrospective real-life analysis of 141 medical records was performed of patients diagnosed with APL between 2007 and 2018, whether they were treated with the IC-APL 2006 protocol or not. Risk factors were assessed by univariate and multivariate analysis. MAIN

RESULTS:

Overall, 112 patients were included in the study. ED occurred in 22.3% of cases, surpassing clinical trial reports, with non-protocol-eligible patients presenting notably higher rates (60%), potentially due to their clinical status. Hemorrhage (60%) and infection (33.3%) were the leading causes of ED. Univariate analysis associated ED to the ECOG score; white blood cell (WBC) count; body mass index; levels of hemoglobin, albumin, uric acid, and creatinine, aPTT and INR and FLT3 mutations. Multivariate analysis identified ECOG score ≥2 and elevated WBC count as independent risk factors.

CONCLUSION:

ED remains a substantial challenge in APL, especially in real-world settings with hemorrhage and infection being the leading causes. ECOG status and WBC count emerged as independent risk factors, while age and platelet count lacked a 30-day prognostic correlation. Evaluating prognostic enhancement tools in controlled trials and real-life settings is pivotal to improving APL outcomes.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hematol Transfus Cell Ther Year: 2024 Document type: Article Publication country: BR / BRASIL / BRASILE / BRAZIL / BRESIL

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hematol Transfus Cell Ther Year: 2024 Document type: Article Publication country: BR / BRASIL / BRASILE / BRAZIL / BRESIL